Julie Cooke

CIK: 0001776977

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (33.3%)

Position reduction

Option Exercises (M)10 (33.3%)

Derivative conversions

Awards (A)4 (13.3%)

Compensation grants

Other (G, F, J, C, D, …)6 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NBIX

NEUROCRINE BIOSCIENCES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (30 total)

NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $156.22$302K
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Award(A)
Direct
3.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Sale(S)
Direct
14.2K shares at avg. $154.83$2.2M
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Sale(S)
Direct
5.5K shares at avg. $155.46$850K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Sale(S)
Direct
3.5K shares at avg. $158.59$558K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Sale(S)
Direct
4.2K shares at avg. $156.77$661K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Sale(S)
Direct
9.5K shares at avg. $157.62$1.5M
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Exercise(M)
Direct
25K shares at avg. $81.49$2.0M
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Award(A)
Direct
10K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
815 shares at avg. $124.12$101K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
5.4K shares at avg. $124.12$668K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
1.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
756 shares at avg. $124.12$94K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
1.5K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Exercise(M)
Direct
1.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Tax Payment(F)
Direct
749 shares at avg. $123.10$92K
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Exercise(M)
Direct
1.7K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Tax Payment(F)
Direct
997 shares at avg. $136.06$136K
NBIX
NEUROCRINE BIOSCIENCES INC
May 16, 2025
Exercise(M)
Direct
6.5K shares at avg. $61.82$400K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Exercise(M)
Direct
1.5K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Sale(S)
Direct
796 shares at avg. $116.77$93K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Exercise(M)
Direct
1.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Sale(S)
Direct
755 shares at avg. $116.80$88K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2025
Award(A)
Stock Option
Direct
29.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2025
Award(A)
Restricted Stock Unit
Direct
5.5K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,936	$156.22	$302,442	Direct
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	3,587	-	$0	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	14,214	$154.83	$2,200,685	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	5,466	$155.46	$849,726	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	3,520	$158.59	$558,236	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	4,216	$156.77	$660,925	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	9,521	$157.62	$1,500,663	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	24,965	$81.49	$2,034,398	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	9,968	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	815	$124.12	$101,158	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	5,378	$124.12	$667,517	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,401	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	756	$124.12	$93,835	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,510	-	$0	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,387	-	$0	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	749	$123.10	$92,202	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,741	-	$0	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	997	$136.06	$135,652	Direct
May 16, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	6,468	$61.82	$399,852	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,509	-	-	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	796	$116.77	$92,946	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,401	-	-	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	755	$116.80	$88,183	Direct
Feb 12, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Stock Option	29,600	-	-	Direct
Feb 12, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Restricted Stock Unit	5,548	-	-	Direct

1-25 of 30 transactions

About Cooke Julie

Cooke Julie (SEC CIK 0001776977) files insider reports with the SEC as Chief Human Resources Officer of NEUROCRINE BIOSCIENCES INC (NBIX).

Signal8 holds 8 ownership filings by Cooke Julie, all Form 4s, filed between Feb 4, 2025 and Sep 15, 2026. Those filings report 30 transactions, from Jan 31, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cooke Julie's filings is in SAN DIEGO, CA.

Recent filings by Cooke Julie

Sep 11, 2026: Tax withholding of NBIX shares (Form 4, code F).
Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
Jun 2, 2026: Open-market sales of NBIX shares (5 lines, Form 4, code S).
Jun 2, 2026: Option exercise of NBIX shares (Form 4, code M).
Feb 13, 2026: Grant or award of NBIX shares (Form 4, code A).

Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)

MORROW GEORGE J, Director
Gano Kyle, Chief Executive Officer
ROBERTS EIRY, Chief Medical Officer
Onyia Jude, Chief Scientific Officer
Lippoldt Darin, Chief Legal Officer
Keswani Sanjay Chandru, Chief Medical Officer

How to read Form 4 transaction codes